Michelle Dipp, Co-Founder of Biospring Partners, discusses focusing investments on new ways of manufacturing from the creation of new drugs to innovations in synthetic biology and gene editing.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Meta Delivers Lackluster Forecast & Microsoft's Cloud Unit Grows
54:46

Cerberus Alumni Mold the Pentagon in Their Private Equity Image
08:48

Chip Stock Rout Deepens on AI Debt Jitters, China Competition
48:13